ERNAWNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations
Market cap
$51.421 K
$0.03 +0.00%
Close of 22 Sept 2026
Revenue
$582.0K
#3524 by revenue
Earnings
-$14.1M
Loss-making
Shares outstanding
1,632,411
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Other share classes
Ernexa Therapeutics lists more than one class of stock. Company figures above cover all classes combined.
Where these numbers come from
Share counts and financials for Ernexa Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.